Showing results (21-30 of 209) with videos related to
Sort By:
Pageof 21
Clinical Lung Cancer|June 11, 2008
Immune modulation as a therapeutic strategy for non-small-cell lung cancerGregory E Holt, Mary L DisisAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Triple-negative breast cancer: immune modulation as the new treatment paradigmMary L Disis, Sasha E StantonClinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2013
Can immunity to breast cancer eliminate residual micrometastases?Mary L Disis, Sasha E StantonBreast Cancer Research and Treatment|August 2, 2002
Delayed type hypersensitivity response to recall antigens does not accurately reflect immune competence in advanced stage breast cancer patientsKathy Schiffman, Kristine Rinn, Mary L DisisExpert Opinion on Therapeutic Targets|January 18, 2007
Targeting serum antibody for cancer diagnosis: a focus on colorectal cancerHailing Lu, Vivian Goodell, Mary L DisisJournal of Proteome Research|March 4, 2008
Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancerHailing Lu, Vivian Goodell, Mary L DisisBMC Immunology|May 31, 2008
His-tag ELISA for the detection of humoral tumor-specific immunityVivian Goodell, Douglas McNeel, Mary L DisisLancet (London, England)|February 24, 2009
Use of tumour-responsive T cells as cancer treatmentMary L Disis, Helga Bernhard, Elizabeth M JaffeeChinese Clinical Oncology|May 10, 2017
Next generation approaches for tumor vaccinationAnand Patel, Howard L Kaufman, Mary L DisisPageof 21